ARCHIVES

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

Army Accepting Letters of Intent For Research in Breast Cancer; Plans Announcement In Sept.

July 16, 1993

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008

Cvitkovic Responds To Story On March ODAC Meeting.

June 23, 2000

Suspect Chemical Include Castor Oil, Witchhazel; Details On 38 Picked For Long Term Tests

August 5, 1977

In Brief: Magnuson Delays Action On Apparitions Bill; No Vote See Now Until September

July 28, 1978